Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors
Articolo
Data di Pubblicazione:
2014
Abstract:
Spasticity is a common disabling symptom of several neurological conditions including stroke. Botulinum toxin type A (BTX-A) injection represents the gold standard therapy for focal spasticity. Post-stroke management of patients receiving BTX-A therapy has been variously investigated, but general agreement on how and when to implement rehabilitation is lacking.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Attitude of Health Personnel; Botulinum Toxins, Type A; Delphi Technique; Disease Management; Humans; Italy; Muscle Spasticity; Neuromuscular Agents; Physician's Practice Patterns; Stroke
Elenco autori:
Franceschini, M; Iocco, M; Molteni, F; Santamato, A; Smania, N; Sandrini, G
Link alla scheda completa:
Pubblicato in: